Fenofibric Acid Capsule, Delayed Release
Product Images NDC 42571-348

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 42571-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibricacid Lbl A

This is a medication bottle containing delayed-release capsules of Choline fenofibrate equivalent to 45 mg of fenofibric acid. The bottle should not be accepted if the seal over the bottle opening is broken or missing. The medication should be stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F). It should be protected from moisture, and the package insert should be referred to for full prescribing information. The remaining text appears to be serial numbers and information regarding manufacturing and distribution.*

FDA Label Image

Fenofibricacid Lbl B

The text provides information on the delayed-release capsule containing Choline Fenofibric Acid and fenofibrate. It warns against accepting the product if its seal is broken or missing. Storage recommendations indicate that it should be kept at 25°C with excursions allowed between 15° to 30°C. The product should be protected from moisture. The package insert should be consulted for complete information on prescription information. Details on the manufacturer, lot number, and expiration date are included.*

FDA Label Image

Fenofibric Acid Structure (Fenofibricacid Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.